We are excited to announce the launch of Desmopressin Acetate Injection, USP in 40mcg/10mL x 1 vial (NDC#39822-6250-1) and 4mcg/mL x 10 vials (NDC# 39822-6200-2) presentations!

XGen Pharmaceuticals DJB, Inc. is pleased to announce the addition of Desmopressin Acetate Injection, USP to their expanding product line. Desmopressin Acetate Injection, USP will be available in single-dose (4 mcg/1 mL) and multi-dose (40 mcg/10 mL) vials, packaged as 10 vials per carton under NDC 39822-6200-2 and individually as 1 vial per carton under NDC 39822-6250-1, respectively.

This product is now available, with full prescribing information available here:
Desmopressin Acetate Injection, USP.

“We are proud of this achievement of introducing Desmopressin Acetate Injection, USP to our portfolio as it marks our 4th product launched in the last year.” Stated Ed Vanderbeck, President of XGEN Pharmaceuticals DJB. “This is indicative of XGen DJB’s continued company vision and pursuit to develop and deliver specialty pharmaceutical products to better serve the healthcare community”